Search Results

3001 - 3025 of 85173
TitleWireDateTime
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2026 in Lincoln Educational Services Corporation Lawsuit - LINC Globe Newswire 11/09 10:05
Levi & Korsinsky Reminds Baidu, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 13, 2026 - BIDU Globe Newswire 11/09 10:03
Veloce Brand, Agency, Esports Partnerships and Quadrant Drive SEGG Media Q2 1,584% Revenue Increase Globe Newswire 11/09 10:00
Reach Security Recognized as a CRN® 2026 Stellar Startup Globe Newswire 11/09 10:00
DTN Announces Three Key Executive Appointments To Drive Innovation and Growth Globe Newswire 11/09 10:00
Freight Club Leadership Joins Freight Right to Build Out Direct-to-Consumer Ecommerce and Dropshipping for Large Goods Globe Newswire 11/09 10:00
Bronstein, Gewirtz & Grossman LLC Urges The Ensign Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm Globe Newswire 11/09 10:00
National Advertising Division Found Unilever’s Dove Deep Moisture Body Wash Claims Supported Globe Newswire 11/09 10:00
The Goddard School Opens 700th School, Marking Major Growth Milestone Globe Newswire 11/09 10:00
Silvercrest Asset Management Group Ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings Among Consultants and Asset Owners in the Mid-Sized Firm Peer Universe Globe Newswire 11/09 10:00
Kraig Labs Ships Spider Silk to Developers Across Global Industries Globe Newswire 11/09 09:55
CloudTalk launches a new AI Sales Dialer for even more live conversations: Customers report going from 15 to 100+ calls per agent per day Globe Newswire 11/09 09:52
Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits Globe Newswire 11/09 09:45
Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits Globe Newswire 11/09 09:45
Texas Capital Bancshares, Inc. Begins Trading on TXSE Under New TXCP Ticker Globe Newswire 11/09 09:45
BIDU Investors Have Opportunity to Lead Baidu, Inc. Securities Fraud Lawsuit with SBS Law Globe Newswire 11/09 09:44
ASTS Investors Have Opportunity to Lead AST SpaceMobile, Inc. Securities Fraud Lawsuit with SBS Law Globe Newswire 11/09 09:39
NJBankers Honors Two Manasquan Bank Team Members, Maria Intili and Talia Jackson, as 2026 Rising Stars Globe Newswire 11/09 09:38
Insight Global Named Presenting Sponsor of the 2026 Mustachio Bashio Charity Event, Benefiting Movember Globe Newswire 11/09 09:37
Qlik Appoints Anna Sharkey as Chief People Officer Globe Newswire 11/09 09:30
Real-World Evidence Solutions Market to worth USD 12.44 Billion by 2031, at a CAGR of 14.9% – MarketsandMarkets™ Globe Newswire 11/09 09:30
Beyond the Piggy Bank: How to Build Your Child’s Financial Future Globe Newswire 11/09 09:30
Performance Shipping Inc. Announces $4.0 Million Share Buyback Plan Globe Newswire 11/09 09:27
USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows Globe Newswire 11/09 09:21
Trump says his deportation policy 'might have been too tough' for voters in the election AP Online 11/09 09:20
3001 - 3025 of 85173

News, Photo and Web Search

Search News by Ticker